Clozapine-induced recurrent pulmonary thromboembolism

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 25, Issue 3, 2013, Pages

  Munoli, Ravindra Neelakanthappa ^a   Praharaj, Samir Kumar ^a   Bhat, Sripathy M ^a  

^a KASTURBA MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; COUMARIN; DIGOXIN; FUROSEMIDE; HALOPERIDOL; SPIRONOLACTONE; STREPTOKINASE; TENECTEPLASE; TRIHEXYPHENIDYL; WARFARIN;

ADULT; AGRANULOCYTOSIS; BLOOD CLOT LYSIS; CASE REPORT; DIABETES MELLITUS; DIASTOLIC HEART MURMUR; DISEASE DURATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LETTER; LOWER EXTREMITY DEEP VEIN THROMBOSIS; LUNG EMBOLISM; LUNG INFARCTION; MALE; MYOCARDITIS; PARANOID SCHIZOPHRENIA; PATIENT REFERRAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECANALIZATION; RECURRENT DISEASE; SEIZURE; SIDE EFFECT; TABLET; TACHYCARDIA; THORAX PAIN; TREATMENT DURATION; TRICUSPID VALVE REGURGITATION; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; MALE; PULMONARY EMBOLISM; SCHIZOPHRENIA, PARANOID;

EID: 84883882334     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.12070186     Document Type: Letter

References (14)

1. Kane J, Honigfeld G, Singer J, et al: Clozapine for the treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
2. Lieberman JA, Kane JM, Johns CA: Clozapine: guidelines for clinical management. J Clin Psychiatry 1989; 50:329-338
3. Hägg S, Joelsson L, Mjörndal T, et al: Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 1998; 59:294-299
4. Kilian JG, Kerr K, Lawrence C, et al: Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354:1841-1845
5. Walker AM, Lanza LL, Arellano F, et al: Mortality in current and former users of clozapine. Epidemiology 1997; 8:671-677
6. Hägg S, Spigset O, Söderström TG: Association of venous thromboembolism and clozapine. Lancet 2000; 355:1155-1156
7. Ihde-Scholl T, Rolli ML, Jefferson JW: Clozapine and pulmonary embolus. Am J Psychiatry 2001; 158:499-500
8. Suttmann I, Dittert S, Landgraf R, et al: Clozapine and sudden death. Lancet 2000; 355:842-843; author reply: 843
9. Maynes D: Bilateral pulmonary embolism in a patient on clozapine therapy. Can J Psychiatry 2000; 45:296-297
10. Lacika S, Cooper JP: Pulmonary embolus possibly associated with clozapine treatment. Can J Psychiatry 1999; 44:396-397
11. Coodin S, Ballegeer T: Clozapine therapy and pulmonary embolism. Can J Psychiatry 2000; 45:395
12. Zornberg GL, Jick H: Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet 2000; 356:1219-1223
13. Hägg S, Jönsson AK, Spigset O: Risk of venous thromboembolism due to antipsychotic drug therapy. Expert Opin Drug Saf 2009; 8:537-547
14. O'Luanaigh C, Scully P: An Irish case of pulmonary emboli secondary to clozapine therapy. Ir J Psychol Med 2006; 23:36-37